Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Aphria Signs Supply Agreement with MBLL to Supply Up to 2.7 Million Grams of Cannabis to the Manitoba Adult-Use Market

Canada NewsWire June 29, 2018

Aphria Announces Closing of Bought Deal Financing

Canada NewsWire June 28, 2018

Data Projects Canadian Cannabis Legalization Will Spur Stronger Growth

PR Newswire June 25, 2018

Aphria's Malta-based subsidiary, ASG Pharma, receives first import license for cannabis issued by the Malta Medicines Authority

Canada NewsWire June 21, 2018

Aphria Applauds Passage of Bill C-45, a Historic Milestone for Canada and the Cannabis Industry

Canada NewsWire June 20, 2018

Medical and Recreational Cannabis Companies With Near Term Catalyst News

PR Newswire June 15, 2018

Aphria Appoints Former Southern Glazer's Executive Joel Toguri as Vice President of Sales

Canada NewsWire June 15, 2018

Aphria Welcomes Passage of Bill C-45 in Senate, Ready to Meet Demand for Adult-Use Cannabis in Canada

Canada NewsWire June 8, 2018

Medical Cannabis Company Raising $225 Million for Expansion

Stockhouse Editorial June 7, 2018

IIROC Trade Resumption - SMU.UN; PL; ZYME; APH; NVU.UN

Canada NewsWire June 7, 2018

Aphria Announces $225 Million Bought Deal

GlobeNewswire June 6, 2018

IIROC Trading Halt - APH

Canada NewsWire June 6, 2018

Aphria to build state-of-the art Extraction Centre of Excellence

Canada NewsWire June 6, 2018

Consumer Spending on the Legal Cannabis Market Projected to Grow

PR Newswire June 1, 2018

How Blockchain is Revolutionizing the Marijuana Industry

PR Newswire May 31, 2018

Aphria Forms Landmark Venture with South African Company Verve Group of Companies

Canada NewsWire May 28, 2018

Can Canada Benefit from too much Weed? Don’t Hold Your Breath

Jonathon Brown May 22, 2018

Canada's Cannabis Boom Could Be Taking Off Soon

PR Newswire May 18, 2018

Aphria's German subsidiary, Nuuvera Deutschland, acquires interest in Berlin-based Shöneberg Hospital

Canada NewsWire May 17, 2018

Aphria selects Great North Distributors, a Canadian subsidiary of Southern Glazer's Wine & Spirits, for Canada-wide distribution of adult-use cannabis

Canada NewsWire May 17, 2018